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ABSTRACT
Steroid hormone receptors (SHRs) are ligand-dependent transcription factors
belonging to the nuclear receptor superfamily. These receptors regulate various
physiological functions in higher ordered eukaryotes. In the absence of hormone these
receptors form a complex with molecular chaperones such as Hsp90 and Hsp70 and
other cochaperones in the cytoplasm. Association with the Hsp90-Hsp70 chaperone
machinery leads to the maturation of the Ligand Binding Domain (LBD) of the receptors
and enables the receptors to bind hormone with high affinity. Upon binding with a
specific hormone the receptors are translocated into the nucleus where they initiate
transcription of specific genes. Although the involvement of the Hsp90-Hsp70
chaperone machinery in steroid hormone receptor function is well-characterized, other
proteins have also been found in the receptor-chaperone complex which are known as
Hsp90 and Hsp70 cochaperones. One such cochaperone is human Small Glutamine
Rich Tetratricopeptide repeat (TPR) containing protein α (SGTα).
SGTα is a Tetratricopeptide (TPR) containing protein which belongs to the Hsp90
chaperone family. SGTα consists of three TPR motifs which mediate interaction with the
C-terminal EEVD motif of Hsp90, Hsp70 and an N-terminal domain which facilitates
self-dimerization of the protein. In addition, recent studies indicated SGTα is a key
participant in Androgen receptor (AR) signaling pathway and negatively affects its
activity. However, the role of SGTα on other steroid hormone receptors still remains
elusive. In this study, we investigated the role of SGTα on other steroid hormone
receptors such as Glucocorticoid (GR), Progesterone (PR), Estrogen (ER) and
Mineralocorticoid (MR).
vi

In order to determine the possible role played by SGTα in other steroid hormone
receptor maturation pathways, we used two model systems, Saccharomyces cerevisiae
and mammalian cell culture. Our results showed that SGTα is also a regulator of
glucocorticoid (GR) and progesterone (PR) receptors’ maturation and activation in a
ligand-dependent manner. For both GR and PR, SGTα was found to downregulate
receptors’ activity in yeast in the presence of hormone. However, this cochaperone was
not found to be involved with the mineralocorticoid and estrogen receptor maturation
pathways. In Hela cells, stable knockdown of endogenous SGTα resulted in an
upregulation of the GR and PR-mediated reporter activity in comparison to the stably
transfected scrambled shRNA as well as wild type cells. Transfection of SGTα in the
stable SGTα knockdown cells resulted in restoration of receptor activity to the wild type
level. Furthermore, our studies in the yeast model system demonstrate that SGTα is a
competitive inhibitor of FK506 binding protein 52 (FKBP52), a well-characterized
immunophilin, which is involved in AR, GR and PR maturation pathways and potentiates
their activity. Assays done in yeast showed that SGTα inhibits FKBP52-mediated
potentiation of AR, GR and PR. Moreover, in vitro studies showed that SGTα and
FKBP52 compete for binding on Hsp90. Collectively, our results indicate that SGTα
partakes in GR and PR complex maturation and down-regulates these receptors’
activity in the presence of hormone. These findings cast new insights on how different
cochaperones specifically interact with different steroid hormone receptors and regulate
their functions.
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CHAPTER1: INTRODUCTION
1.1 Steroid Hormone Receptor Maturation.
Steroid hormone receptors, members of the nuclear receptor superfamily, are
ligand-dependent transcription factors which mediate various physiological functions in
cells including development, homeostasis, reproduction, growth etc. In the absence of
the appropriate hormone, the receptors remain in cytoplasm in complex with heat shock
protein 90 (Hsp90) (1-4) and other chaperones and co-chaperones as reviewed by
Pratt and Toft (5). Molecular chaperones and co-chaperones play an important role in
the maturation of the receptors to the hormone binding conformation (6). The receptorchaperone complexes are assembled in an ordered fashion that dictates the maturation
of the receptor. This pathway is depicted in the Figure 1. In the cytoplasm, Hsp40 first
interacts with the receptor after being translated on the ribosome (7). This interaction is
followed by association with Hsp70 (8) which is mediated in an ATP-dependent manner.
ATP binds with the N-terminal domain of Hsp70 while the J-domain of Hsp40 interacts
with Hsp70 and stimulates its ATPase activity. This in turn results in tight association of
Hsp70 with the receptor (9). The binding of Hsp70 facilitates the folding process and
paves the way for association with the Hsp90 complex (10, 11). At this point Hsp70
recruits Hsp interacting protein (Hip), Hsp organizing protein (Hop) and Hsp90. Hop acts
as a scaffolding protein which connects Hsp70 with the Hsp90 complex and modulate
their activities (12, 13). Association of Hsc70-interacting protein (CHIP) in the complex
acts as a quality control monitor, which contains a U-box ubiquitin ligase domain that
directs the misfolded receptors to the proteosome for degradation (14, 15). Addition of
Hsp90 to the complex stabilizes the hormone binding domain (HBD) of the receptor and
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renders the receptor to remain soluble in the cytoplasm (16). Following association of
Hsp90, a rearrangement ensues which triggers the dissociation of Hsp70 and
recruitment of the p23 cochaperone along with one of several immunophilin proteins as
2

well as other co-chaperones to the receptor complex (17). This transposition renders
the receptors in a structural conformation with hormone binding affinity. This mature
conformation of the receptors lasts for a very short time which correlates with the slow
ATPase cycle of Hsp90 (18, 19). In the absence of hormone, the receptor is cycled back
into the chaperoning pathway. However, the presence of hormone triggers the
dissociation of the complex and translocates the receptor into the nucleus where it
dimerizes and binds to hormone response elements (HRE) thereby enhancing the
expression of the target genes responsible for growth, homeostasis, differentiation, and
reproduction in higher ordered eukaryotes (20).
1.2 Association of TPR proteins in Steroid Hormone Receptor Complexes.
Heat shock protein 90 (Hsp90) and heat shock protein 70 (Hsp70) are highly
conserved molecular chaperones in eukaryotic cells which help in proper folding of their
client proteins like steroid hormone receptors (17). Although Hsp90 and Hsp70 are the
key players in steroid hormone receptor maturation and activation, multiple proteins
have been found to be associated with this machinery and regulate their chaperone
activity. A common feature shared by those proteins involved in this process is the
presence of the TPR (Tetratricopeptide repeat) motif which helps in protein-protein
interaction (20). Table 1 lists the various TPR-containing proteins known to be involved
in steroid hormone receptor maturation along with the domain organization of these
proteins. The TPR motif was first identified in proteins involved in the cell division cycle
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(CDC) in yeast (21, 22). The TPR motif consists of 3-16 tandem arrays of 34 amino
acids. The different TPR motifs can be distributed in the protein sequence. X-ray
crystallography revealed that each of the TPR motifs consists of anti-parallel α helices.
Adjacent TPR motifs pack in a parallel arrangement resulting in a spiral of repeating
anti-parallel α helices (23). Protein Phosphatase 5 (PP5) was the first identified TPR
protein

involved

in

steroid

hormone

receptor

maturation

(24).

Since

then

crystallographic analysis of several proteins involved in steroid hormone receptor
complexes have been revealed to have one or more TPR domains (e.g. Hip, Hop, Chip,
Cyp40, FKBP52, FKBP51) (11). Although all the detectable TPR motifs present in a
protein are not necessarily functional, mutation in the TPR region of these proteins not
only alters their interaction specificity but also has functional consequences for the cell
indicating that the TPR motif is functionally important (23).
4

1.3 SGTα as a TPR-containing protein.
Although, association of different TPR proteins in the steroid hormone receptor
complex is well characterized, the list of proteins involved in this process continues to
expand. One such newly identified TPR protein is human small glutamine-rich TRP
containing protein α (SGTα). SGTα was first identified as a TPR containing protein
which interacts with Nonstructural Protein NS1 of Parvovirus H-1 and found to be
located both in the cytoplasm and nucleus (25). Later yeast two-hybrid screening
demonstrated SGTα interacts with severe acute respiratory syndrome coronavirus
(SARS-CoV) protein 7a which induces apoptosis when overexpressed in a variety of
cell types. Deletion mutant analysis showed TPR2 of SGTα (aa 125-158) was crucial for
this interaction (26). In addition, independent studies showed that SGTα interacts with
HIV-1 viral encoded protein U (Vpu) the viral core protein precursor Gag (27) and
overexpression of the TPR region of SGTα inhibits HIV-1 particle release (27). Dutta et
al (2008) showed that the central TPR domain of SGTα is enough to interact with Vpu
and overexpression of TPR domain inhibits the HIV-1 particle release (28). Although
much remains to be elucidated about the mechanism of how SGTα inhibits viral particle
release, together these findings indicate SGTα plays a crucial role during viral infection.
Understanding the interaction between viral proteins and SGTα thus could lead to novel
therapeutic intervention in treating viral infection.
The first reported homologues of human SGTα were in Saccharomyces cerevisiae
(SGT2) and Caenorhabtidis elegans (29). The highest degree of similarity was found to
be present in the central region containing three TPR motifs in tandem array. Later
Ommen et al (2009) showed SGTα is conserved from invertebrate to the higher ordered
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vertebrates such as zebrafish, frog, and chicken and is essential for viability of
Leishmania donovani (30). Deletion of the yeast homologue (SGT2) of human SGTα in
yeast resulted in defects in the ability of the yeast to recover from heat shock (38). Zhu
et al (2003), showed SGTα interacts with the N-terminal region of myostatin (31). In
humans, SGTα was found to be present in all tissues tested and mapped to
chromosome 19p13 (29). Mass spectrometry analysis showed SGTα interacts with
human β amyloid peptide (Aβ) along with five other chaperone proteins (32).Moreover,
2-D gel electrophoresis analysis identified SGTα as a phosphoprotein pointing out that
this protein may be involved in a variety of cellular functions including signal
transduction, transcriptional regulation, and enzymatic regulation (33). Furthermore,
Winnefeld et al (2004) showed that transient transfection with siRNA targeting
endogenous SGTα in a variety of cell types results in mitotic arrest which is followed by
cell death implying the possible roles of SGTα in cell cycle (34). In brief, these findings
indicate that SGTα is an essential protein which is conserved through various
organisms and plays crucial roles in various cellular processes.
SGTα consists of three structural units – an N-terminal domain which facilitates

self-association (dimerization) of the protein, three TPR domains for protein-protein
interaction and a C-terminal glutamine-rich domain which is able to interact with
hydrophobic amino acid segments within polypeptides (Figure 2) (35). Yeast two-hybrid
screening showed SGTα interacts with heat shock cognate protein 70 (Hsc70) via c-
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terminal GPTIEEVD peptide (36, 37). More recently, by “Far-Western” and pull-down
assays, Angeletti et al (2002) demonstrated SGTα interacts with Hsp70 and negatively
regulates its chaperone activity suggesting its regulatory role in the chaperone complex
(38). Furthermore, the TPR domain of SGTα has also been reported to interact with
Hsp90. The C-terminal EEVD motif deletion mutant of Hsp90 was found no longer to be
associated with SGTα pointing out the fact that SGTα binds with Hsp90 via this domain
(39).

Together, these findings indicate that SGTα is a molecular cochaperone

belonging to the Hsp90-Hsp70 chaperone family.
Recently, GST pull-down assay showed SGTα interacts with growth hormone
receptor and the first TPR motif is responsible for interacting with the ubiquitindependent endocytosis motif of the receptor (40). However, most importantly, Buchanan
et al (2007) showed that SGTα plays a role in androgen receptor (AR) mediated
prostate cancer indicating the possible involvement of SGTα in the steroid hormone
receptor complex. The expression of SGTα in prostate cancer epithelial cells was found
to be second only to that of FKBP52, an immunophilin involved in the steroid hormone
receptor maturation pathway. Overexpression of SGTα in prostate cancer cells was
found to down-regulate DHT (dihydrotestosterone) mediated androgen receptor
transactivation activity. Moreover, knocking down SGTα with specific siRNA in C4-2B
cells resulted in a marked increase in basal and DHT-mediated AR activity. Taken
together; these findings implicate the possible involvement of SGTα in the androgen
receptor-chaperone complex and plays a key role in the AR maturation pathway (41).

7

1.4 Objectives.
To date, Hsp90 and Hsp70 have been identified as the chaperone partner of SGTα.
However, interaction of SGTα with Hsp90 and Hsp70 does not provide much insight
about its function. The study done by Buchanan et al (2007) showed its role as an
Androgen receptor (AR) specific Hsp70/Hsp90 cochaperone TPR partner. In vivo it was
found to promote cytoplasmic retention of the receptor and plays a role in the sensitivity
and specificity of the receptor (40). However, the role of SGTα on other steroid hormone
receptors (GR, PR, MR, ER) still remains elusive. These steroid hormone receptors play
crucial roles in normal growth, development, homeostasis, metabolism, and
reproduction. Misfolding of these receptors by the proteins involved in the chaperone
complex thus could lead to disease conditions. Therefore, a more detailed
understanding of the steroid hormone receptors and the proteins involved in the
maturation and activation of these receptors is necessary in order to understand the
development and progression of different diseases and to the development of effective
treatments. Given that SGTα is a key regulator of AR activity, it remains possible that
SGTα is a relevant regulator of other steroid hormone receptors. With recent
identification and characterization of different TPR proteins in the receptor-chaperone
complex, it is becoming evident that these co-chaperones contribute to and facilitate
receptor maturation and regulate receptor activity in a significant manner. Therefore,
the main objective of this study is to characterize the effects of SGTα on different
steroid hormone receptors. This may cast meaningful insights into cochaperone
specificity of different steroid hormone receptors and their role in receptor maturation.

8

CHAPTER 2: MATERIALS AND METHODS
2.1 Yeast Strains and Hormone Induction Assays.
β-Galactosidase reporter assays were used as quantitative measurement of the
receptor activity (42). The W303α (MATα leu2-112ura3-1 trp1-1 his3-11, 15 ade2-1
can1-100 GAL SUC2) yeast strain was used for all the yeast hormone induction assays.
For the SGT2 deletion-complementation assay, BY4742 (MATα his3delta1, leu2delta0,
lys2delta0, met3delta0, ura3delta0) as wild type and SGT2 knock out (MATα his3delta1,
leu2delta0, lys2delta0, met3delta0, ura3delta0, sgt2::Kanr) yeast strains were obtained
from Open Biosystems (Huntsville, AL). Yeast cells were trasformed by standard lithium
acetate procedure (43) and were plated on synthetic complete (SC) medium containing
2% glucose, 0.5% ammonium sulfate, 0.015% adenine sulfate, 0.17% yeast nitrogen
base, 2% agar and complete supplemental mixture lacking specific amino acids. Parent
strains were co-transformed with three plasmids: a constitutive receptor expression
plasmid, a hormone-inducible β-Galactosidase reporter plasmid, and an SGTα (or
SGT2 for Figure 2) expression vector or empty vector as a control. For each receptormediated reporter assay, the hormone (ligand) concentrations were optimized in order
to maximize the difference between cells carrying an empty vector versus cells carrying
SGTα expression vector by performing dose-response curves. Hormone-induced
reporter activity was measured from yeast extracts as described previously (42). All
assays were performed at least three times with all variables measured in duplicate.
2.2 Generation of Stable SGTα Knock down HeLa Cells.
Plasmid Construction: To obtain SGTα knockdown (SGTKD) HeLa cells, distinct short
hairpin

RNA

(shRNA)

sequences

containing
9

inverted

repeats

(sense,

ATAAATAGGCGTTGTGACCTC;

antisense,

GAGGTCACAACGCCTATTTAT)

separated by a loop (TTCGAGACG) were designed. The oligos targeting SGTα were
designed as a synthetic duplex with overhanging sites for restriction digestion (BamHI-5’
end and HindIII-3’ end). The oligos were heated to 900C for 3 min and then cooled to
370C for 1 hr for annealing reaction. The ligation reaction was performed with the
annealed shRNA and BamHI and HindII digested pSilencer 2.1-U6 vector (Applied
Biosystems, Foster City, CA) at room temperature for 2 hr. The ligation product was
transformed into DH5α competant cells. Positive clones were confirmed by
sequenceing. A scrambled shRNA was also constructed to exclude any shRNA specific
effects. A blast search was performed to ensure that the scrambled construct has no
significant homology with any known functional mRNA sequence. A second shRNA
construct was also made in a similar way (sense, ACTTTGAAGCTGCCGTGCA;
antisense, TGCACGGCAGCTTCAAAGT; loop TTCGAGACG) to ‘rule-out’ any off-target
effects.
Stable SGTα Knockdown Cell Line (SGTKD): For stable transfection, HeLa cells
were plated in petridishes in Hyclone MEM/EBSS media (Thermo Scientific, Waltham,
MA) containing 10% fetal bovine serum (FBS) 24 hrs prior to transfection. At 80%
confluence, shRNA targeting SGTα as well as scrambled shRNA were transfected by
Lipofectamine 2000 method according to the manufacturers instructions (Invitrogen,
Carlsbad, California) followed by selection with Hygromycin (Thermo Scientific,
Waltham, MA). Individual colonies were isolated and screened for effective knockdown
of endogenous SGTα protein levels by western blot. The selected clone was used to
perform the luciferase reporter assasys. Also, the scrambled shRNA construct was
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stably transfected into HeLa cells to demonstrate the effects were not due to nonspecific knockdown of cellular proteins in general.
2.3 Mammalian Cell Lines and Hormone Induction Assays.
For the reporter-mediated receptor assays, wild type HeLa cells, SGTα
knockdown (SGTKD) cells and cells with stably transfected scrambled shRNA were
cultured at 5% CO2 in MEM supplemented with 10% charcoal-stripped FBS and
essential amino acids. Cells were plated at a cell density of 6×105 in 6-well plates. At
80% confluence, the cells were transfected for 4 hours using Lipofectamine 2000
(Invitrogen, Carlsbad, CA) at a DNA (μg):Lipofectamine (μl) ratio of 1:3 in MEM lacking
FBS according to manufacturer’s instructions. For the reporter activity three plasmids
(800 ng each plasmid/well) were transfected - a hormone-responsive firefly luciferase
reporter, a mammalian expression vector (pCI-neo; Promega, Madison, WI) carrying
steroid hormone receptor, and an empty mammalian expression vector (pCI-neo;
Promega, Madison, WI) or a mammalian expression vector (pCI-neo; Promega,
Madison, WI) carrying SGTα. As a control for transfection efficiency each well was also
transfected with 50 ng of a constitutive β-galactosidase expression plasmid. For the PR
assays a mammalian expression vector carrying progesterone receptor was also
transfected but not for the GR assays since HeLa cells have endogenous GR. 24 hours
post-transfection, cells were treated with appropriate hormone along with vehicle control
(ethanol). The cells were lysed 48 hours after transfection in M-PER (Pierce, Rockford,
IL). Luciferase activity was measured by adding 40 µl of cell lysate with 100µl of
luciferase reagent (Promega, Madison, WI) in an opaque 96-well plate. β-galactosidase
activity was assayed by adding 20 µl of the cell lysate with 100 µl Tropix Gal-Screen
11

assay reagent (Applied Biosystems, Foster City, CA) in an opaque 96-well plate. The
96-well plates were incubated at room temperature until maximum luminescence
developed (about 5 min for the luciferase assay and 2 hours for the β-galactosidase
assays). After normalizing for transfection efficiency (relative light units/β-galactosidase
activity), the data were plotted as fold induction of luciferase activity over background
activity observed in the absence of hormone. All assays will be performed at least three
times with all variables measured in duplicate.
2.4 Yeast two-hybrid assay.
Yeast two-hybrid assays were performed according to manufacturer’s recommendation
(Matchmaker GAL4 Two-Hybrid System 3). Briefly, SGTα was used as bait and
glucocorticoid (GR) or progesterone (PR) receptors were used as prey. The yeast twohybrid vectors pGADT7 (encoding Gal4 Activation domain) and pGBKT7 (encoding
Gal4 DNA binding domain) were obtained from Clonetech. SGTα was fused with Gal4
DNA-binding domain (pGBKT7: SGTα). The progesterone receptor in pGADT7 vector
(pGADT7:PR) was a kind gift from Dr. Miguel Beato (Centre de Regulacio´ Genomica,
Universitat Pompeu Fabra) and the GR in pGADT7 vector (pGADT7:GR) was kindly
provided by Dr. Kaju Yanai (Department of Biomolecular Science Faculty of Sciences,
Toho University). The resulting plasmids were co-transformed in combinations as
indicated into the yeast strain AH109 and plated on Synthetic complete medium lacking
leucine and tryptophan (SC/−leu/−trp). Cotransformats were selected to grow to detect
HIS3 activation by selecting for on SC plates deficient in Leucine, tryptophan and
histidine (SC/−leu/−trp/-his).

12

2.5 Protein Purification.
Plasmids carrying Hsp90, FKBP52 and SGTα were cloned into pET28a(+) vector
and transformed individually into BL21(DE3) E. coli. The colonies were picked and
grown overnight. 30 ml of each overnight culture were grown in 1000 ml media in
shaking incubator at 370C until the OD600 reached 0.6. Protein expression was induced
with Isopropyl β-D-1-thiogalactoside (IPTG) to a final concentration of 1mM.

The

cultures were grown for an additional 4 hrs and centrifuged at 6000 rpm for 20 min. The
pellets were resuspended in 12 ml lysis buffer (20 mM Tris HCl, 300 mM NaCl, 10 mM
Imidazole, pH 8) and divided into 3, 4 ml aliquots. 40 ul of 100 mg/ml Lysozyme was
then added to each 4 ml cell suspension and incubated for 20 minutes at 300C. To lyse
the cells, each of the 4 samples were then sonicated and kept on ice. The 4 aliquotes
were pulled together and centrifuged at 15,000 rpm for 20 mins at 40C. To purify the
protein, the 12 ml lysate was loaded onto the Ni-NTA column pre-equilibrated with lysis
buffer and mixed for 1 hour at 40C. The resin was then washed with buffer (20 mM Tris
HCl, 300 mM NaCl, 20 mM Imidazole, pH 8) and transferred to a 2 ml gravity flow
column. 10 ml of elution buffer (20 mM Tris HCl, 300 mM NaCl, 250 mM Imidazole, pH
8) was used to elute the proteins. All proteins were dialyzed extensively against 50mM
Hepes, 50mM KCl, 10mM MgCl2, 1mM DTT (pH 7.4) prior to sample concentration and
storage at -80°C.
2.6 In vitro binding assay.
To carry out the in vitro binding assay, 10 ul of protein-A-sepharose beads was
incubated with anti- SGTα antibody (Protein Tech Group, Chicago, IL) or rabbit nonimmune serum (Santa Cruz Biotechnology, Santa Cruz, CA) in 460 µl of Binding buffer
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at room temperature for 30 min with gentle shaking. The antibody bound resins were
then washed 3 times with binding buffer. 20 µg of purified SGTα was added in each
reaction as bait for the pull-down assay to a final volume of 400 µl with binding buffer.
The reactions were then incubated on ice for one hour with gentle mixing. The reactions
were washed 3 times with binding buffer. Equimolar concentrations of Hsp90 and
FKBP52 were then added to the reaction and incubated at 300C for 1 hour to a final
volume of 400 µl with binding buffer. The reactions were washed 3 times with binding
buffer and eluted with 2X sample buffer. The samples were then heat denatured and
run on 10-20% Criterion gels (Bio-Rad, Hercules, CA) for western blot analysis.
2.6 Westernblot.
Yeast cells growing overnight were diluted (OD600 approximately to 0.2) and
grown until the OD600 reached 0.8. Yeast cells were then pelleted, resuspended in 2X
SDS-PAGE sample buffer and vortexed vigorously in the presence of glass beads. Cells
were then centrifuged at 13,200 rpm for 20 min at 40C. For mammalian cell lysis, cells
were washed with 1X PBS and lysed with mammalian protein extraction reagent (MPER; Pierce, Rockford, IL) supplemented with protease inhibitors (Complete mini
EDTA-free; Roche, Indianapolis, IN). Protein concentrations for mammalian extracts
were determined by Coomassie Plus Protein Assay (Pierce, Rockford, IL).
Approximately 20 µg total cellular protein was added with 2X SDS-PAGE sample buffer,
heat denatured at 950C for 5 minutes and separated on a 10-20% Criterion gel (BioRad, Hercules, CA). Separated protein was transferred to PVDF membranes. The
following antibodies were used: rabbit α-human SGTα (Protein Tech Group, Chicago,
IL), rabbit α-human AR (Santa Cruz Biotechnology, Santa Cruz, CA ), rabbit α-human
14

GR (Santa Cruz Biotechnology, Santa Cruz, CA), and mouse anti-chicken PR (PR-22).
Antibodies detecting yeast ribosomal protein L3 (44) and Glyceraldehyde-3-phosphate
dehydrogenase (6C5; Biodesign International, Saco, MN) were used as loading
controls. The secondary antibodies were alkaline phosphatase-conjugated goat antimouse or anti-rabbit antibodies and bands were visualized with Immune-Star AP
substrate (Bio-Rad, Hercules, CA) and exposed to X-ray film.
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CHAPTER 3: RESULTS AND DISCUSSION
3.1 Comparative Analysis of human SGTα and yeast SGT2.
As identified by Kordes et al, 1998 (25), SGT2 is the yeast homologue of human
SGTα. Amino acid sequence analysis of revealed that these two proteins share 29.8%
identity and 45.3% similarity at the amino acid level (Figure. 3). The highest degree of
homology was observed in the centrally located TPR domain which consists of three
TPR motifs. However, yeast SGT2 does not have a glutamine rich C-terminal domain

and the level of homology in the N-terminal domain is also not significant (17.7%
identity, 35.4% similarity). Although yeasts lack steroid hormone receptors, homology in
the TPR region of SGTα and SGT2 suggests that the TPR domain is the functional
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domain for both these proteins and that these two proteins may work in a similar
fashion.
3.2 Functional Homology between human SGTα and yeast SGT2.
To this end, virtually all steroid hormone receptors have been reconstituted in the
S. cerevisiae (43). Therefore, co-expression of the receptor and a reporter gene (βgalactosidase) carrying hormone response elements (HRE) along with SGTα may
indicate the possible involvement of this protein in the steroid hormone receptor
signaling pathways. In this study we used the yeast homologue of human SGTα, SGT2,
which share 29.8% identity. The SGT2 deletion yeast strain (Δsgt2) serves as negative
background in which SGTα and SGT2 can be studied.
In order to determine the functional homology between SGTα and SGT2,
wild type and Δsgt2 yeast strains carrying androgen receptor (AR) and β-galactosidase
reporter expression vectors were transformed with empty vector or vector carrying
SGTα or SGT2. The findings indicate that deletion of SGT2 from yeast resulted in 2-fold
increase in the androgen receptor-mediated reporter activity in comparison to the wild
type cells. However, overexpression of SGTα resulted in a decrese in the receptormediated reporter activity to the wild type level (data not shown). These assays suggest
that human SGTα and yeast SGT2 are functional homologs. In addition, the effects of
SGTα observed on androgen receptor function are similar to what would be expected
from previously published data in a mammalian cell system (41).
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3.3 Defects in Cell growth in Δsgt2 Yeast Cells.
Although the Δsgt2 strain serves as a negative background to study the effects of
SGTα and SGT2 in yeast, deletion of SGT2 results in defects in yeast which prevents
further characterization of SGT2. Deletion of the S. cerevisiae homolog, SGT2, has
been reported to result in a cell wall defect and abnormal cell cycle progression (46, 47).
Thus, over a short period of time the deletion strain becomes sick and the data obtained
from those cells becomes inconsistent. In order to confirm this, both wild type and Δsgt2
yeast strains were grown at 300C (Figure 4) and diluted serially on Yeast extractpeptone-dextrose (YEPD plate). The results indicate the SGT2 deletion cells display a

growth defect at optimal growth temperature. This finding was similar with results shown
by Angeletti et al (2002) where Δsgt2 strain showed to have defects in recovery from
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heat shock (37). Given the abnormal growth phenotypes displayed by the deletion
strain, this particular strain is not ideal for the functional study of SGTα. However, SGTα
consistently and significantly reduces AR function in the wild type parent strain. Thus,
overexpression of human SGTα in the wild type yeast strain carrying a receptor
expression plasmid and the receptor-responsive reporter plasmid can serve as an
exploratory system for the functional characterization of SGTα effects in steroid
hormone receptor signaling pathways.
3.4 Role of SGTα on Different Steroid Hormone Receptor Signaling Pathways in a
Yeast Model System.
As discussed above, SGTα has been reported to be AR-specific. However,
effects on receptors other than AR and ER have not been explored. Thus, it is possible
that SGTα functionally affects other steroid hormone receptors. To determine the
possible role of SGTα in different steroid hormone receptor pathways, wild type yeast
carrying a steroid hormone receptor expression vector and a β-galactosidase reporter
were transformed with an SGTα expression vector. Addition of specific ligand (hormone)
resulted in ligand-dependent, receptor-mediated expression of the lacZ reporter gene.
The readout of β-galactosidase activity (lacZ units) indicates the functional status of the
steroid receptors. Our results suggest that SGTα is a potential regulator of the
androgen, glucocorticoid and progesterone receptor signaling pathways. However, no
effects were observed on the estrogen and mineralocorticoid receptors upon SGTα
overexpression.
Androgen Receptor (AR): The W303α yeast cells were transformed with an
expression vector carrying the androgen receptor, a β-galactosidase reporter plasmid,
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and the SGTα expression vector or empty parent vector. The transformed strains were
assayed for receptor-mediated expression of the β-galactosidase reporter gene. The
results in Figure 5 indicate SGTα negatively regulates androgen receptor activity in
comparison to empty vector control. Western blot analysis showed that all proteins are
expressed properly and that the reduction in receptor activity observed is not due to
reduced receptor expression and/or stability. The yeast ribosomal protein L3 was used
as a loading control.
Glucocorticoid

Receptor (GR):

In order to determine the effects of SGTα on

glucocorticoid receptor the W303α yeast cells were transformed with an expression
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vector carrying the glucocorticoid receptor, a β-galactosidase reporter plasmid, and the
SGTα expression vector or empty parent vector. The results showed in Figure 6

indicate that SGTα is also a modulator of glucocorticoid receptor in the yeast model
system. Overexpression of SGTα resulted in downregulation of GR activity in a liganddependent manner. Although, hormone-independent receptor activity was seen, in most
of the cases the results were not statistically significant. Therefore, it is difficult to draw
any conclusion of hormone-independent effects of SGTα on glucocorticoid receptor.

21

The western blot analysis showed the effects were not due to degradation in the protein
level.
Progesterone Receptor (PR):

As seen in glucocorticoid

and androgen receptor,

overexpression of progesterone receptor and reporter in yeast cells carrying SGTα
results in hormone (progesterone) dependent downregulation of progesterone receptor
activity (Figure7). The presence of

SGTα

resulted in a two-fold decrease in the

receptor activity. As descibed above the Western blot showed that the proteins were
expressed properly.
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Estrogen and Mineralocorticoid Receptors (ER & MR): In contrary to androgen,
glucocorticoid and progesterone receptors, SGTα was found to have no effect on the
estrogen and mineralocorticoid receptors in receptor-mediated β-galactosidase reporter
assays in the yeast model system. As depicted in Figure 8 for both MR and ER SGTα

was not found to affect the activity of these receptors both in hormone-dependent as
well as in a hormone-independent manner. These data suggest that SGTα does not
regulate the estrogen and mineralocorticoid receptors.
Constitutive β-Gal Assay: In order to demonstrate that the effects observed on steroid
hormone receptor signaling were not due to a general alteration in overall cellular
transcription, translation, and protein stability, yeast cells carrying a constitutive βgalactosidase reporter were transformed with empty vector and SGTα. Both the vector
and SGTα transformed yeast cells showed the same level of activity which validates the
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fact that SGTα does not generally affect cellular transcription or translation but it
specifically mediates steroid hormone receptor signaling (Figure 9).
3.5 Validation of Yeast Assay Results in a Mammalian Cell Culture System.
The yeast-based assays provided much evidence regarding the possible
involvement of SGTα in androgen, progesterone and glucocorticoid

receptors

maturation and function. Although yeast genetics provides a powerful tool for
characterizing steroid hormone receptor modulators, the yeast system must be viewed
as an exploratory system. The data gleaned from yeast should therefore be validated in
higher vertebrate model systems to ascertain physiological relevance. HeLa cells have
been viewd as an excellent model system in steroid hormone receptor studies. Along
with their high transfection efficiency and high growth rate, HeLa cells have endogenous
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glucocorticoid receptor at a level appropriate to carry out receptor-mediated reporter
assays. Together, all these attributes make HeLa cells a suitable model system to
confirm physiological relevance of SGTα in steroid hormone receptor signaling.
Buchanan et al (2007) has already demonstrated that SGTα is a key modulator in
androgen receptor signaling in mammalian cell lines (41). Therefore, emphasis was
placed on assessing the possible interaction and involvement of SGTα in glucocorticoid
and progesterone receptor signaling pathways. Western blot analysis revealed that
SGTα is present in all human cell lines that we have tested including HeLa cells. Thus,
knockdown/complementation experiments were performed in HeLa cells in order to
assess the importance of SGTα
As described in Chapter 2, HeLa cells were stably transfected with a specific
shRNA expression plasmid targeting endogenous SGTα. Plasmids carrying the shRNA
have a hygromycin antibiotic resistance gene. Therefore, 48 hrs post-transfection cells
were maintained in media containing hygromycin antibiotic. This allowed for the
isolation and clonal selection of cells carrying a stably integrated copy of the shRNA for
SGTα. Western blot analysis confirmed the reduction in protein level in the screened
clones and the clone with the highest degree of knockdown was choosen to perform the
luciferase assays. Additionally, control HeLa cells carrying a stable copy of a randomly
scrambled shRNA was constructed to control for knockdown specificity.
Glucocorticoid Receptor: In order to determine the role of SGTα in the glucocorticoid
receptor signaling pathway, wild type, scrambled shRNA and SGTα knock down
(SGTKD) HeLa cell lines were transfected with a luciferase reporter plasmid, a
constitutive β-galactosidase reporter plasmid to control for transfection efficiency, and
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an SGTα expression vector or empty control vector. Since HeLa cells express high
levels of the glucocorticoid receptor endogenously, there was no need to transfect in a
plasmid for receptor expression in this instance. The data in Figure 10 indicates that
knockdown of endogenous SGTα resulted in an upregulation of glucocorticoid receptor
activity in comparison to the wild type and scrambled shRNA transfected HeLa cells.
However, overexpression of SGTα in the SGTKD resulted in restoration of the receptor
activity to the wild type level. In addition, cells carrying the scrambled shRNA did not
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differ in activity from the wild type cells. As shown in Figure 11 GAPDH expression was
unaffected by the treatment with either SGTα shRNA or scramled shRNA, indicating
that non-specific downregulation of protein expression was not induced by SGTα

shRNA treatment. In brief, this data suggest that SGTα is involved in the GR signaling
pathway and downregulates receptor activity.
Progesterone Receptor: Similar assays were performed in wild type HeLa cells and
SGTKD cell lines to resolve the possible involvement of SGTα in the progesterone
receptor (PR) signaling pathway. Since HeLa cells do not have endogenous
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progesterone receptor, wild type cells, scrambled shRNA and SGTKD HeLa cell lines
were transfected with plasmids carrying a luciferase reporter gene, a β-galactosidase
expression vector and empty vector along with a progesterone receptor expression

vector. Also, to determine if overexpression of SGTα in the SGTKD cells can lead to
restoration of the receptor activity, cells were transfected with an SGTα expression
vector. As demonstrated by the data presented in Figure 12 it is clear that upon SGTα
knock down, progesterone receptor activity was upregulated in contrast to wild type and
scramble

shRNA

transfected

cells

in
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a

hormone-dependent

manner

while

Figure 13

overexpression of SGTα restored the receptor activity to the wild type level. Figure 13
illustrates the western blot analysis of the assay. Notably, the GAPDH (Glyceraldehyde
3-phosphate dehydrogenase) level was unaffected due to stable transfection of SGTα
shRNA or scrambled shRNA.
Taken togethether, these results indicate SGTα is a key participant in the
glucocorticoid

and progesterone receptor maturation pathways and downregulates

receptor activity.
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Alternative shRNA construct to validate knock down effects:
To rule out potential “off-target” effects due to shRNA-mediated knockdown, an
additional shRNA construct was made and stably transfected into the HeLa cell line.
Glucocorticoid receptor-mediated reporter assays were carried out in a similar way.

The findings shown in Figure 14 confirmed the effects observed on both the
glucocorticoid and progesterone receptors are due to specific knockdown of SGTα in
the cells.
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3.6 Determination of Physical Interaction between SGTα and the ReceptorChaperone Complex.
The assays performed in both yeast and mammalian cell lines suggest SGTα is a
potential modulator in glucocorticoid and Progesterone receptor signaling pathways.
Previous studies demonstrated that SGTα interacts with Hsp90 and Hsp70 (21, 22) and
regulates their activity. However, it is still unclear whether SGTα directly interacts with
the receptor-complex. Therefore, the next logical step would be to determine if SGTα
regulates the receptor activity by directly interacting with the receptor-chaperone
complex.
Yeast two-hybrid screening is a powerful tool to screen possible protein-protein
interactions. Many weak protein-protein interactions can be abolished with the use of
increasingly stringent selection conditions. Since the proteins are maintained in their
native conformation in yeast cells, it is possible to identify even the weak interactions
between different proteins by yeast two-hybrid screening. Albers et al (2004) have
demonstrated yeast-two hybrid screening as a potential approach to assess nuclear
receptor interacting proteins (48). We are using the SGTα gene as bait and expressing
as a fusion to the GAL4 DNA-binding domain (pGBKT7: SGTα). Glucocorticoid and
progesterone receptors were expressed as a fusion to the GAL4 activation domain as
prey (pGADT7:GR and pGADT7:PR). Transforming these plasmids into specific yeast
strains will bring the activation and DNA binding domain in close proximity and if SGTα
interacts with GR or PR, will trigger the transcription of GAL4 reporter gene which will
allow the yeast cells to grow in specific amino acid-deficient medium. Therefore, yeast
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two-hybrid screening should be considered as an ideal system to analyze the interaction
between SGTα and GR and PR.
pGADT7:GR and pGBKT7: SGTα plasmids were co-transformed into the yeast
strain AH109 obtained from Clontech. Empty plasmids lacking either GR or SGTα were
also transformed as a control where indicated. (pGADT7:pGBKT7, pGADT7: SGTα,
pGBKT7:GR). In addition, pGBKT7-53 (murine p53 in pGBKT7) and pGADT7-T (SV40
large T-antigen in pGADT7) were also co-transformed as a positive control. Murine p53

and SV40 large T-antigen are known interacting partners in the yeast two-hybrid
system. As a negative control, human lamin C fused with DNA-BD (pGBKT7-Lam) was
co-transformed with pGADT7-T in AH109 strain. Human lamin C and SV40 large Tantigen do not interact with each other. Therefore, this ruled out fortuitous interaction
between two proteins. As shown in Figure 15 co-transformed colonies were grown in
medium with or without histidine. All co-transformants grew similarly in non-selective
medium (Figure 15. A). However, when plated on selective medium (SC-LWH), only
yeast cells expressing GAL4DBD- SGTα and GAL4AD-GR grew (Figure 15. B) along
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with the positive control (GAL4DBD-53 and GAL4AD-T). Together, these results
indicate that SGTα interacts with the GR-Hsp90 complex in a yeast two-hybrid system.
To investigate the possible interaction between human PR and SGTα, similar
transformations were carried out along with the abovementioned positive and negative
controls. As shown in Figure 16. A, all co-transformed colonies grew similarly in the
non-selective medium. However, when they were grown in selective medium lacking
histidine (SC-LWH), as shown in Figure 16. B , yeast cells expressing GAL4DBD- SGTα
and GAL4AD-PR grew along with the positive control (GAL4DBD-53 and GAL4AD-T).
Absence of growth in the negative control (GAL4DBD-Lam and GAL4AD-T) as well as
in the cells transformed with empty vectors with or without receptor and SGTα
combinations indicate this is not a fortuitous interaction between the receptor and
SGTα. Together, these finding indicate that SGTα interacts specifically with
glucocorticoid and progesterone receptor complexes.
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3.7 SGTα inhibits FKBPP52-mediated potentiation of AR and GR in yeast model
system.
One of the best characterized co-chaperones (immunophilin) in the steroid hormone
receptor complex is FK506 binding protein 52 (FKBP52) which potentiates androgen,
progesterone, and glucocorticoid receptor function (5). FKBP52 is a TPR protein that
acts on the receptor-Hsp90 complex through binding to the C-terminal

EEVD motif on Hsp90. Given that SGTα is a TPR protein that also interacts with Hsp90
through the C-terminal EEVD motif on Hsp90, we investigated if the mechanism by
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which SGTα negatively regulates the receptors is at least partially through the
competitive inhibition of FKBP52 binding to the complex. In support of this idea is the

fact that SGTα is a specific negative regulator of the same receptors regulated by
FKBP52. To test this idea we assayed receptor function with FKBP52 and SGTα alone
or in combination in yeast-based assays. Since mammalian cells have both
endogenous SGTα and FKBP52, yeast appeared to be as the ideal model system to
perform these assays. As shown in Figures 17 and 18, these data demonstrate that coexpression of SGTα can effectively shutdown the ability of FKBP52 to potentiate
androgen and glucocorticoid receptor function in a dose-dependent manner. Western
35

blot analysis showed that the effects observed in AR and GR activity were not due to
degradation of the proteins. Interestingly, co-transformation of FKBP52 and SGTα was
found to make these proteins more stable than when transformed individually. The
yeast L3 ribosomal protein level was same for all the transformants validating the
finding that both FKBP52 and SGTα were more stable when co-transformed. However,
it is important to note that SGTα alone can negatively affect receptor function as
FKBP52 is not present in the yeast system. Thus, although SGTα may be able to
competitively inhibit FKBP52 it can also affect receptor function alone.
3.8. Comparative Analysis of FKBP52 and SGTα in normal and tumor tissues.
Western blot analysis of normal and tumor tissue samples showed that both
FKBP52 and SGTα protein level were present in almost all the reproductive tissues
testes along with brain, lung and liver (Figure 19). Importantly, the expression of these
two proteins was higher in tumor samples than in normal human tissue samples. This is
indicative of the fact that these two proteins playing roles in normal physiological
conditions as well as during carcinogenesis.
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3.9. In vitro competitive inhibition of FKBP52 and SGTα for Hsp90 binding.
Furthermore, we investigated the competition between FKBP52 and SGTα in in vitro coimmunoprecipitations. Since both FKBP52 and SGTα compete for binding on the Cterminal EEVD motif on Hsp90, purified Hsp90, FKBP52 and SGTα were used for
analysis

by

co-immunoprecipitation.

Briefly,

anti-SGTα

antibody

(Santa

Cruz

Biotechnology) was used to pull down Hsp90 and FKBP52 along with a rabbit nonimmune serum antibody as control. To do this experiment we used equimolar
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concentrations of Hsp90 and SGTα along with either equimolar or higher concentrations
of FKBP52 (where indicated). As shown in Figure 20, neither of the proteins
immunoprecipitated with the rabbit non-immune serum or anti-SGTα antibody when
used to pull-pull down individual proteins. However, when with anti-SGTα antibody in
the reaction containing Hsp90 and SGTα, Hsp90 was detected as its interacting partner.
This interaction however diminished when we used equimolar or higher concentration of
FKBP52 to the same reaction. The first three lanes showed the purified proteins as
positive control. These results demonstrate that FKBP52 and SGTα compete for binding
Hsp90 and that FKBP52 has a stronger binding affinity for Hsp90 than SGTα.
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CHAPTER 4: DISCUSSION AND FUTURE DIRECTIONS
4.1. Discussion
Hsp70 and Hsp90 are well-characterized molecular chaperones that partake in a
myriad of cellular functions (50-55). Steroid hormone receptors are among the first
identified client proteins for the Hsp90 chaperone (20). In addition to their effects on
steroid hormone receptor folding, both Hsp70 and Hsp90 concentrate the cochaperone
activity within the complex (49). Among the well-characterized co-chaperones involved
in the steroid hormone receptor complex are the large members of the FK506 binding
family of immunophilins (FKBP51 and FKBP52). FKBP52 and FKBP51 were shown to
share approximately 70% amino acid identity. FKBP52 was found to influence receptor
hormone binding and potentiate receptor activity for AR, GR and PR (56-60). Although
FKBP51 was known to antagonize the action of FKBP52 for a considerable period,
recent studies done by Ni et al, 2010 cast new insights of how FKBP51 promotes
androgen receptor signaling in prostate cancer cells. The findings indicate that FKBP51
is overexpressed in hormone refractory prostate cancer (HRPC) cells and regulates ARdependent transcription and cell growth (61). Interestingly, using biomolecular
complementation and coimmunoprecipitation techniques another group identified a
novel FK506 binding protein (FKBPL) that interacts with the glucocorticod receptor (GR)
complex and regulates its activity. FKBPL was classified as a newly identified member
in the receptor-chaperone complex (62). In addition, Chadli et al (2006) identified a
novel cochaperone, GCUNC-45 which was considered to act in folding and activity of
myosin (63), as a novel positive regulator for progesterone receptor (64). Moreover,
Okada et al (2004) identified S100A1 as a novel cochaperone that interacts with Hsp90,
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Hsp70, Cyp40 and FKBP52 (65). Later studies showed that the TPR domain in both
Cyp40 and FKBP52 were the domain for interaction with the S100A1 protein (66).
Collectively, these findings indicate that we are about to understand biochemical and
molecular interactions between different known as well as previously unknown cochaperones and steroid hormone receptor-chaperone complex. Interestingly, as
reviewed by Didier Picard, different steroid hormone receptors have different
cochaperone specificity (16) and thus regulate receptor activity in different ways.
Therefore, a detail understanding of the co-chaperones involved in different steroid
hormone receptor maturation pathways is crucial to understand the roles of these cochaperones on steroid hormone receptor maturation and activity.
In this study, we investigated the possible roles played by SGTα in different
steroid hormone receptor signaling pathways. SGTα was previously known to interact
with Hsp90 and Hsp70 and found to be involved only in the androgen receptor signaling
pathway (41) among all steroid hormone receptors. Here we report SGTα is also a
potential modulator of GR and PR signaling pathways. We exploited yeast as an
exploratory model system to investigate the role of SGTα in different steroid hormone
receptor maturation pathways. Also, our findings in the mammalian cell culture system
confirmed that SGTα downregulates GR and PR activity in a dose-dependent manner.
Since, both SGTα and FKBP52 have specificity for the same receptors (AR, GR, PR)
and SGTα interacts with C-terminal EEVD motif on Hsp90, which also serves as
interacting domain for FKBP52, we examined the presence of FKBP52 and SGTα in the
reproductive tissues. Western blot showed both proteins are present in all human
reproductive tissues tested and their levels were increased in the tumor samples.
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Although, it is difficult to hypothesize the mechanisms of how the effects of FKBP52 and
SGTα on SHRs alter during carcinogenesis in different tissues, it is clear that the
elevated level of expression observed in our study indicate these two co-chaperones
may play some roles during cancer progression. However, further studies must be
conducted to confirm the changes that take place during cancinogenesis.
Although Hsp70 and Hsp90 do not have considerable amino acid similarity, they
share a consensus motif at the C-terminus. Both of these proteins terminate with an
EEVD motif which is recognized by most of the TPR containing proteins (20). Studies
performed with an EEVD deletion mutant demonstrated that the EEVD motif is required
for interaction with TPR proteins (36, 37, 39). However, the affinity of different TPR
proteins for binding with Hsp90 is not well-known. Nevertheless, it always remains a
possibility that some proteins interact with the chaperone complex with higher affinity
than others. Although, it is difficult to pursue this question in vivo, in vitro analysis
between SGTα and FKBP52 showed FKBP52 has a stronger binding affinity for Hsp90
and knocks off SGTα from the complex (Figure 16). In spite of the inhibitory effects of
FKBP52 on SGTα for binding on Hsp90 and thereby dissociating SGTα from the
complex, it is important to note that SGTα can downregulate receptor activity even in
absence of FKBP52 (Figure 3, 4,5). Since yeasts don’t have either SGTα or FKBP52,
this served as an ideal model to examine the inhibitory effects of SGTα and FKBP52 on
each other in terms of receptor activity. The assays showed functional competition
between these two proteins on AR and GR activity (Figures 14 and 15). As postulated
by Davies et al, (2005), FKBP52 has a higher affinity for association with the GR-Hsp90
complex followed by protein phosphatase 5 and FKBP51 (67). Although our in vitro
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studies showed competition between FKBP52 and SGTα, further studies must be
pursued to confirm these findings in physiological conditions.
In summary, our findings demonstrate that SGTα is a potential modulator of the
GR and PR maturation pathways that directly interacts with the receptor-chaperone
complex and alters receptor activity. With these findings, SGTα can be classified as a
new cochaperone to the burgeoning cochaperone diversity of the steroid hormone
receptor complex.
4.2. Future Directions
Over the past couple of decades significant progress have been made in
understanding the role of molecular chaperones and co-chaperones , especially TPR
proteins. These co-chaperones were not only found to have a role in client protein
folding but also to be involved in various cellular and biochemical processes. Recent
findings showed that Fkbp52 -/- female mice have compromised PR function and fail to
support blastocyst implantation (68). Also a case-control study showed that alteration in
TPR cochaperone FKBPL leads to male infertility (69). In addition, two other recently
identified Hsp70-associated TPR containing co-chaperones HBP21 and DYX1C1 have
been implicated in breast cancer progression (70). Collectively, these findings indicate
that TPR co-chaperones play significant roles in normal cellular processes as well as
during cancer progression and, therefore, can be viewed as potential therapeutic
targets. Interestingly, SGTα has recently been identified as a candidate gene for
polycystic ovary syndrome (PCOS) (71). Moreover, studies done by Buchanan et al,
(2007) showed that SGTα downregulates AR activity in a hormone-independent manner
and helps in cytoplasmic retention of AR in prostate cancer cells (41). The presence of
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SGTα in all human tissues tested and the elevated levels in tumor samples imply its
putative involvement in normal signaling cascades as well in tumorigenesis. Our data
suggests SGTα is also a possible regulator of GR and PR. Additionally, our data
indicates SGTα inhibits FKBP52-mediated potentiation of AR and GR in a yeast model
system. Collectively, these data signify SGTα as a potential modulator of steroid
hormone receptor maturation and signaling pathways. Receptor specificity for both
SGTα and FKBP52 and competitive inhibition between these two TPR proteins as found
in both the yeast model system as well as in in vitro studies point out that SGTα could
be targeted as a potential biological inhibitor for FKBP52. Although the precise
mechanism still remains elusive, it is tempting to speculate that SGTα may serve as a
molecular buffer in controlling the aberrant gene expression mediated by steroid
hormone receptors during cancer. Further studies should be directed to gain knowledge
about the mechanism of how SGTα regulates receptor maturation and how this
functioning is altered during tumorigenesis. This will not only help to understand the
molecular events behind the receptor maturation but will also provide valuable insights
to target proteins like SGTα to specifically disrupt the receptor-chaperone complex.
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